Omalizumab-A review

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.

Saved in:
Bibliographic Details
Main Authors: Kiran Godse (Author), Aayushi Mehta (Author), Sharmila Patil (Author), Manjyot Gautam (Author), Nitin Nadkarni (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.
Item Description:0019-5154
1998-3611
10.4103/0019-5154.160490